Roberts Brandi
Definium Therapeutics, Inc. · Chief Financial Officer
Roberts Brandi is listed in filings as Chief Financial Officer at Definium Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 22, 2026, including 9 public disclosures. Recent filings connect the profile to Definium Therapeutics, Inc. (DFTX) and Longboard Pharmaceuticals, Inc. (LBPH). The current snapshot covers public activity from Oct 29, 2024 to Jun 22, 2026. Reported amounts are shown as $1.8M to $520.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||